Valproic acid Completed Phase 2 Trials for Intermittent Explosive Disorder Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00078754A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder